Log in
/
Register
Home
Overview
Upload / Manage Data
Browse / Search Studies
Analyze Studies
Tutorials
FAQ
Data Repository
Overview
Upload / Manage Studies
Browse / Search Studies
Analyze Studies
Data Sharing Policy
Tutorials
FAQ
Databases
Overview
RefMet: Metabolite Nomenclature
Metabolite Database
Human Metabolome Gene/Protein Database (MGP)
External Metabolomics Databases (Links)
Protocols
Overview
General Protocols
Study-specific Protocols
Tools
Overview
Load and analyze your own dataset
Analyze Studies
MS Searches
Structure drawing
REST Service
External Tools (Links)
About
Overview
Publishing Partners
How to Cite
How to Link
Terms of Use
Personnel
Contact
Sitemap
Search
Keyword Search
Advanced Searches
Return to Statistics Toolbox
OPLS-DA analysis for Study ST003917
(Analysis AN006430 )
Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1
Experimental factor
Group2
Age_at_screening (years):1.1 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):1.1 | Sex:Male | Visit:Baseline | Treatment:Placebo | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):1.1 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):1.1 | Sex:Male | Visit:End of Avoidance | Treatment:Placebo | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):1.1 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):1.1 | Sex:Male | Visit:End of Treatment | Treatment:Placebo | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):1.4 | Sex:Female | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):1.4 | Sex:Female | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):1.4 | Sex:Female | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):1.4 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):1.4 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):1.4 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):1.5 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):1.5 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):1.5 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):1.9 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):1.9 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):1.9 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):2.1 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):2.1 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):2.1 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):2.2 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):2.2 | Sex:Male | Visit:Baseline | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.2 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):2.2 | Sex:Male | Visit:End of Avoidance | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.2 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):2.2 | Sex:Male | Visit:End of Treatment | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.3 | Sex:Female | Visit:Baseline | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.3 | Sex:Female | Visit:End of Avoidance | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.3 | Sex:Female | Visit:End of Treatment | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.3 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):2.3 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):2.3 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):2.4 | Sex:Female | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):2.4 | Sex:Female | Visit:Baseline | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.4 | Sex:Female | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):2.4 | Sex:Female | Visit:End of Avoidance | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.4 | Sex:Female | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):2.4 | Sex:Female | Visit:End of Treatment | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.6 | Sex:Female | Visit:Baseline | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.6 | Sex:Female | Visit:End of Avoidance | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.6 | Sex:Female | Visit:End of Treatment | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.6 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.6 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):2.6 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.6 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):2.6 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.6 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):2.7 | Sex:Female | Visit:Baseline | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.7 | Sex:Female | Visit:End of Avoidance | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.7 | Sex:Female | Visit:End of Treatment | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.8 | Sex:Male | Visit:Baseline | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.8 | Sex:Male | Visit:End of Avoidance | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.8 | Sex:Male | Visit:End of Treatment | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.1 | Sex:Female | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.1 | Sex:Female | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.1 | Sex:Female | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.1 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.1 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):3.1 | Sex:Male | Visit:Baseline | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.1 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.1 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):3.1 | Sex:Male | Visit:End of Avoidance | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.1 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.1 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):3.1 | Sex:Male | Visit:End of Treatment | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.2 | Sex:Female | Visit:Baseline | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.2 | Sex:Female | Visit:End of Avoidance | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.2 | Sex:Female | Visit:End of Treatment | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.2 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.2 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.2 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.3 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.3 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.3 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):3.3 | Sex:Male | Visit:Baseline | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.3 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.3 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.3 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):3.3 | Sex:Male | Visit:End of Avoidance | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.3 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.3 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.3 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):3.3 | Sex:Male | Visit:End of Treatment | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.4 | Sex:Female | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.4 | Sex:Female | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.4 | Sex:Female | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.4 | Sex:Female | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.4 | Sex:Female | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.4 | Sex:Female | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.4 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.4 | Sex:Male | Visit:Baseline | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.4 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.4 | Sex:Male | Visit:End of Avoidance | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.4 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.4 | Sex:Male | Visit:End of Treatment | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.5 | Sex:Female | Visit:Baseline | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.5 | Sex:Female | Visit:End of Avoidance | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.5 | Sex:Female | Visit:End of Treatment | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.5 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.5 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D-R+ | Remission:Yes | Desensitized:No
Age_at_screening (years):3.5 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.5 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D-R+ | Remission:Yes | Desensitized:No
Age_at_screening (years):3.5 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.5 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D-R+ | Remission:Yes | Desensitized:No
Age_at_screening (years):3.6 | Sex:Male | Visit:Baseline | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.6 | Sex:Male | Visit:End of Avoidance | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.6 | Sex:Male | Visit:End of Treatment | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.7 | Sex:Female | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.7 | Sex:Female | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.7 | Sex:Female | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.9 | Sex:Female | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.9 | Sex:Female | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.9 | Sex:Female | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.9 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.9 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):3.9 | Sex:Male | Visit:Baseline | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.9 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.9 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):3.9 | Sex:Male | Visit:End of Avoidance | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.9 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.9 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):3.9 | Sex:Male | Visit:End of Treatment | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3 | Sex:Female | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3 | Sex:Female | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3 | Sex:Female | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3 | Sex:Female | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3 | Sex:Female | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3 | Sex:Female | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):4 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):4 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):4 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Metabolomics Workbench
Terms of use
Site map
Contact